Talphera, Inc.(TLPH)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-25 | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Purchase | +213,310 | +36.31%800,705 | $0.59 | $125,000 | View SEC filing | |
| 2026-02-20 | Aslam Shakil Chief Medical Officer | Purchase | +35,000 | +72.65%83,178 | $0.81 | $28,431 | View SEC filing | |
| 2026-02-20 | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Purchase | +105,364 | +22.32%577,395 | $0.81 | $85,587 | View SEC filing | |
| 2026-02-20 | ASADORIAN RAFFI Chief Financial Officer | Purchase | +45,000 | +103.87%88,323 | $0.81 | $36,554 | View SEC filing | |
| 2026-02-20 | Dasu Badri N Chief Engineering Officer | Purchase | +35,000 | +90.01%73,884 | $0.81 | $28,431 | View SEC filing | |
| 2025-04-03 | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Purchase | +213,310 | +81.58%474,769 | $0.59 | $125,000 | View SEC filing | |
| 2025-02-26 | Aslam Shakil Chief Medical Officer | Purchase | +5,695 | +17.80%37,695 | $1.06 | $6,038 | View SEC filing | |
| 2024-12-06 | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Purchase | +5,000 | +2.46%208,066 | $0.64 | $3,200 | View SEC filing | |
| 2024-12-02 | ASADORIAN RAFFI Chief Financial Officer | Sale | -155 | -0.41%37,578 | $0.77 | $119 | View SEC filing | |
| 2024-12-02 | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Purchase | +5,000 | +2.52%203,066 | $0.73 | $3,650 | View SEC filing | |
| 2024-09-03 | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Purchase | +7,260 | +3.80%198,066 | $1.05 | $7,598 | View SEC filing | |
| 2024-06-14 | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | +5.85%180,806 | $0.99 | $9,856 | View SEC filing | |
| 2023-12-14 | Angotti Vincent J. Chief Executive Officer | Purchase | +10,000 | +10.89%101,805 | $0.73 | $7,268 | View SEC filing | |
| 2023-09-11 | Angotti Vincent J. Chief Executive Officer | Purchase | +10,000 | +12.22%91,805 | $0.80 | $7,950 | View SEC filing | |
| 2023-08-25 | Palmer Pamela P Chief Medical Officer | Sale | -16,956 | -35.54%30,753 | $1.13 | $19,236 | View SEC filing | |
| 2022-06-08 | Angotti Vincent J. Chief Executive Officer | Purchase | +46,400 | +4.78%1,016,919 | $0.22 | $10,333 | View SEC filing | |
| 2020-06-15 | ADAMS ADRIAN Director | Purchase | +100,000 | +126.98%178,750 | $1.29 | $128,900 | View SEC filing | |
| 2020-06-15 | ADAMS ADRIAN Director | Purchase | -100,000 | -35.87%178,750 | $1.29 | $128,900 | View SEC filing | |
| 2020-06-15 | Angotti Vincent J. Chief Executive Officer | Purchase | +7,547 | +1.64%468,757 | $1.33 | $10,035 | View SEC filing | |
| 2019-11-12 | EDWARDS MARK G Director | Purchase | +25,000 | +11.43%243,750 | $1.78 | $44,575 | View SEC filing | |
| 2019-11-12 | Angotti Vincent J. Chief Executive Officer | Purchase | +8,379 | +3.13%275,944 | $1.79 | $14,973 | View SEC filing | |
| 2019-08-26 | EDWARDS MARK G Director | Purchase | +15,000 | +7.36%218,750 | $2.19 | $32,806 | View SEC filing | |
| 2019-06-06 | Angotti Vincent J. Chief Executive Officer | Purchase | +5,000 | +1.94%262,884 | $2.31 | $11,550 | View SEC filing | |
| 2019-03-12 | EDWARDS MARK G Director | Purchase | +19,000 | +10.50%200,000 | $2.99 | $56,890 | View SEC filing | |
| 2019-03-04 | ASADORIAN RAFFI Chief Financial Officer | Purchase | +3,647 | +3.02%124,397 | $2.81 | $10,248 | View SEC filing |
1-25 of 92